Clinical Trials Consulting & Training Lt - Accounts to registrar (filleted)

REGISTERED NUMBER: 06386114 (England and Wales)

Clinical Trials Consulting

& Training Limited

Unaudited Financial Statements for the Year Ended 31st March 2026

Page

Company Information

1

Balance Sheet

2

Notes to the Financial Statements

4

DIRECTORS:

Dr. S J Day

Mrs. N D M Day

SECRETARY:

Mrs. N D M Day

REGISTERED OFFICE:

53 Portway

North Marston

Buckingham

Buckinghamshire

MK18 3PL

REGISTERED NUMBER:

06386114 (England and Wales)

ACCOUNTANTS:

Courts Accountancy Services Ltd

Investment House

24 Vicarage Road

Winslow

Buckinghamshire

MK18 3BE

FIXED ASSETS

Tangible assets

4

2,455

1,594

CURRENT ASSETS

Debtors

5

13,550

23,705

Cash at bank

425,809

397,533

439,359

421,238

CREDITORS

Amounts falling due within one year

6

10,980

(10,671

)

NET CURRENT ASSETS

428,379

431,909

TOTAL ASSETS LESS CURRENT
LIABILITIES

430,834

433,503

CAPITAL AND RESERVES

Called up share capital

100

Retained earnings

430,734

433,403

SHAREHOLDERS' FUNDS

430,834

433,503

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31st March 2026.

The members have not required the company to obtain an audit of its financial statements for the year ended 31st March 2026 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 19th May 2026 and were signed on its behalf by:

Dr. S J Day - Director

1.	STATUTORY INFORMATION

Clinical Trials Consulting & Training Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Plant and machinery etc

-

25% on reducing balance

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits

The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2025 - 2 ) .

4.	TANGIBLE FIXED ASSETS

Plant and

machinery

etc

£

COST

At 1st April 2025

5,697

Additions

1,582

At 31st March 2026

7,279

DEPRECIATION

At 1st April 2025

4,103

Charge for year

721

At 31st March 2026

4,824

NET BOOK VALUE

At 31st March 2026

2,455

At 31st March 2025

1,594

5.

DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

31.3.26

31.3.25

£

Trade debtors

13,550

23,705

6.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

31.3.26

31.3.25

£

Trade creditors

60

56

Taxation and social security

10,920

(12,073

)

Other creditors

-

1,346

10,980

(10,671

)

7.	DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to directors subsisted during the years ended 31st March 2026 and 31st March 2025:

31.3.26

31.3.25

£

Dr. S J Day and Mrs. N D M Day

Balance outstanding at start of year

-

(3,946

)

Amounts repaid

-

3,946

Amounts written off

-

Amounts waived

-

Balance outstanding at end of year

-